133 related articles for article (PubMed ID: 18831962)
1. Changes in arginase isoenzymes pattern in human hepatocellular carcinoma.
Chrzanowska A; Krawczyk M; Barańczyk-Kuźma A
Biochem Biophys Res Commun; 2008 Dec; 377(2):337-340. PubMed ID: 18831962
[TBL] [Abstract][Full Text] [Related]
2. Arginase isoenzymes in human cirrhotic liver.
Chrzanowska A; Gajewska B; Barańczyk-Kuźma A
Acta Biochim Pol; 2009; 56(3):465-9. PubMed ID: 19636440
[TBL] [Abstract][Full Text] [Related]
3. Significance of arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatment.
Chrzanowska A; Graboń W; Mielczarek-Puta M; Barańczyk-Kuźma A
Clin Biochem; 2014 Aug; 47(12):1056-9. PubMed ID: 24713397
[TBL] [Abstract][Full Text] [Related]
4. Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma.
Cheng PN; Leung YC; Lo WH; Tsui SM; Lam KC
Cancer Lett; 2005 Jun; 224(1):67-80. PubMed ID: 15911102
[TBL] [Abstract][Full Text] [Related]
5. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells.
Li H; Meininger CJ; Hawker JR; Haynes TE; Kepka-Lenhart D; Mistry SK; Morris SM; Wu G
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E75-82. PubMed ID: 11120661
[TBL] [Abstract][Full Text] [Related]
6. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
[TBL] [Abstract][Full Text] [Related]
7. [New insights into arginase. Part I. Structure and characteristics].
Mielczarek-Puta M; Chrzanowska A; Barańczyk-Kuźma A
Postepy Hig Med Dosw (Online); 2008 May; 62():206-13. PubMed ID: 18480736
[TBL] [Abstract][Full Text] [Related]
8. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
Sang W; Gulinar A; Wang CH; Sheng WQ; Maiweilidan Y; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):538-42. PubMed ID: 24246920
[TBL] [Abstract][Full Text] [Related]
9. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension.
Louis CA; Reichner JS; Henry WL; Mastrofrancesco B; Gotoh T; Mori M; Albina JE
Am J Physiol; 1998 Mar; 274(3):R775-82. PubMed ID: 9530245
[TBL] [Abstract][Full Text] [Related]
10. Expression of arginase isozymes in mouse brain.
Yu H; Iyer RK; Kern RM; Rodriguez WI; Grody WW; Cederbaum SD
J Neurosci Res; 2001 Nov; 66(3):406-22. PubMed ID: 11746358
[TBL] [Abstract][Full Text] [Related]
11. Transformation of primary human hepatocytes in hepatocellular carcinoma.
Montalbano M; Rastellini C; Wang X; Corsello T; Eltorky MA; Vento R; Cicalese L
Int J Oncol; 2016 Mar; 48(3):1205-17. PubMed ID: 26717856
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
[TBL] [Abstract][Full Text] [Related]
14. Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma.
Wu L; Li L; Meng S; Qi R; Mao Z; Lin M
J Gastroenterol Hepatol; 2013 Feb; 28(2):365-8. PubMed ID: 23339388
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
[TBL] [Abstract][Full Text] [Related]
16. Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications.
Yu H; Yoo PK; Aguirre CC; Tsoa RW; Kern RM; Grody WW; Cederbaum SD; Iyer RK
J Histochem Cytochem; 2003 Sep; 51(9):1151-60. PubMed ID: 12923240
[TBL] [Abstract][Full Text] [Related]
17. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
[TBL] [Abstract][Full Text] [Related]
18. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages.
Louis CA; Mody V; Henry WL; Reichner JS; Albina JE
Am J Physiol; 1999 Jan; 276(1):R237-42. PubMed ID: 9887201
[TBL] [Abstract][Full Text] [Related]
19. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
Park YM; Choi JY; Byun BH; Cho CH; Kim HS; Kim BS
Exp Mol Med; 1998 Mar; 30(1):35-40. PubMed ID: 9873820
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic implications of arginase expression in hepatocellular carcinoma.
Mao H; Gao W; Lu G; Fang F; Teng L
Clin Lab; 2013; 59(1-2):37-43. PubMed ID: 23505904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
